Silence Therapeutics plc (SLN) stock chart

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30

$19.80+0.03 (+0.15%)

Close on Nov 12, 2026Market cap $935.48MP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?